|
 Contact us regarding Bextra; attorney consultations are free.
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. read more »
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature read more »
Jan. 18, 06: Recalled Pain Reliever - Bextra – Remains a Hot Issue for Consumers and Lawyers as Lawsuits Ad
Los Angeles, California (PRWEB) January 18, 2006 -– Lawsuits continue to be filed against Pfizer, the maker of Bextra, although Bextra was removed from U.S. and Canadian shelves months ago. Bex... read more »
Dec. 16, 05: Health Canada bars painkiller Bextra from returning to Canadian market
TORONTO (CP) - The painkiller Bextra will not be allowed back on the Canadian market, Health Canada announced Friday. read more »
What is Bextra?
Prior to being removed from the market at the request of the FDA, Bextra was prescribed to deal with symptoms of osteoarthritis, rheumatoid arthritis and painful menstrual cycles. Bextra has the generic name of valdecoxib, and was marketed by Pfizer. Bextra is a member of the class of drugs known as non-steroidal anti-inflammatory drugs, also known as NSAIDs. Bextra and other NSAIDs are used in the treatment of pain and inflammation. Other well-known NSAIDs include aspirin and ibuprofen. Within this class of NSAIDS, Bextra is a cox-2 inhibitor, which is a classification Bextra shares with other high profile drugs that have been featured in the media recently, Vioxx and Celebrex. Vioxx was also voluntarily removed from the market by its manufacturer, Merck & Co., after it was linked to an increased risk of negative cardiovascular side effects like heart attack and stroke, in those to whom it was prescribed. Celebrex, marketed by Pfizer, currently remains available on the market; however Celebrex now carries a "black box warning" concerning possible increased negative cardiovascular side effects. The black box warning is the most severe warning the FDA can give for a drug, short of having the drug pulled from the marketplace entirely. These cox-2 inhibitors are designed to assist in relieving the pain and inflammation that arthritis patients suffer from, by blocking the cox-2 enzyme that creates prostaglandins in the body. Decreasing these prostaglandins helps the body in reducing pain and inflammation.
Contact us regarding Bextra; attorney consultations are free.
« Back to Bextra page
|
|
| | |
